And if the no-licence fee and no-milestone fee research partnership with Medicxi is anything more than a footnote in the Quarterly Report one would be even more concerned. The QR report is supposed to summarise activities from Jan - Mar. The Medicxi early stage research partnership was announced to the ASX in April.
Will the CEO buy her first parcel of shares in SPL today? Why is she still not a shareholder? What message is this sending? Maybe she’s waiting for 10 cents.
And if the no-licence fee and no-milestone fee research...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.44M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 11.5¢ | $56.36K | 470.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 380984 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 208677 | 7 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
0.000 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 12.0¢ | 11.5¢ | 298643 | ||
| Last updated 14.03pm 14/05/2024 ? | |||||
| SPL (ASX) Chart |